- Raised $800k grant, Jul 2020
- Raised $1.9M funding round, Jul 2018
About
Serenus.AI specializes in the development of advanced Generative AI technologies that empower medical decisions at critical medical crossroads on patient pathways, saving lives and valuable resources. Our flagship product is the first (registered patent and 4 patents pending) clinically objective, Generative AI, automated case-by-case system to improve decision-making before medical procedures and treatments, while prioritizing patients' waiting lists. Serenus.AI advanced the quality and equality of healthcare delivery, saves valuable resources, and boosts patients', physicians', and payers' satisfaction across the board.
The system's algorithms replicate the objective decision-making processes of top physicians by combining up-to-date medical practices, professional knowledge, and machine-learning technologies.
The Serenus.AI solution is compatible with every type of health system, including US insurance companies and public health systems. The solution has been validated in practice, and the company is currently active in Europe and the United States with stakeholders in the healthcare field.
Funding history · 2 rounds · $2.7M total
Q&A
- What is Serenus.AI's primary focus?
- Serenus.AI specializes in Generative AI technologies to empower medical decisions, particularly for patient pathways and prioritizing waiting lists, aiming to save lives and resources.
- When was Serenus.AI founded?
- Serenus.AI was founded in March 2017.
- How many employees does Serenus.AI have?
- Serenus.AI has 1-10 employees.
- What is Serenus.AI's total funding to date?
- Serenus.AI has raised a total of $2,700,000 USD.
- Which investors participated in Serenus.AI's July 2018 funding round?
- The July 2018 funding round for Serenus.AI included investors such as Firstime VC and thetime.
- What was Serenus.AI's most recent funding event?
- Serenus.AI received an $800,000 USD Grant from the BIRD Foundation in July 2020.
- What is the current stage of Serenus.AI?
- Serenus.AI is currently in the Seed stage.
- Does Serenus.AI hold any patents?
- Yes, Serenus.AI holds one registered patent and has four patents pending for its Generative AI system.
- Who are the co-founders of Serenus.AI?
- The co-founders of Serenus.AI are Hillary (Orly) Harel (CEO), Dan Berachowitz, and Prof. Josef Elidan (CMO).
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | serenusai.com |
|---|---|
| linkedin.com/company/12992715 | |
| facebook.com/SerenusAI | |
| YouTube | youtube.com/channel/UCwJgL9kSG74FKzyZmFgkkBg |
Identifiers & details
| Founded | 2017-3 |
|---|---|
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | serenusai.com |
|---|